General Practice · Marion, IN
NPI
1447220900
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1391 N Baldwin Ave
Marion, IN, 46952
Phone (765) 660-7630
Groups this clinician bills Medicare through
Medicare paid, 2024
$327K
11,887 services
Medicare patients, 2024
921
Average age 76
Drug cost, 2024
$2.9M
27,926 prescriptions
Company payments, 2025
$584
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James M Orrell was code J0897 (injection, denosumab, 1 mg), 1,020 times for 11 patients. In total James M Orrell billed 11,887 services in 43 codes, and Medicare paid $327K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,020 | 11 | $16.83 | $17K |
| 99214 Office E&M - Established | Office | 930 | 632 | $81.11 | $75K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 560 | 560 | $121.38 | $68K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 358 | 335 | $10.73 | $3,842 |
| G0008 Administration of influenza virus vaccine | Office | 304 | 304 | $30.00 | $9,120 |
| 90673 Vaccine Product | Office | 288 | 288 | $81.25 | $23K |
| 99213 Office E&M - Established | Office | 239 | 218 | $49.87 | $12K |
| 96372 Injection Administration | Office | 98 | 35 | $10.21 | $1,000 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 85 | 85 | $154.48 | $13K |
| 90677 Vaccine Product | Office | 73 | 73 | $280.83 | $21K |
| G0009 Administration of pneumococcal vaccine | Office | 72 | 72 | $30.10 | $2,167 |
| 99215 Office E&M - Established | Office | 47 | 47 | $119.27 | $5,605 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 34 | 32 | $150.86 | $5,129 |
| 99212 Office E&M - Established | Office | 33 | 33 | $31.93 | $1,054 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 29 | 18 | $31.13 | $903 |
By year: 2022 $190K for 6,511 services; 2023 $281K for 11,884 services; 2024 $327K for 11,887 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87635 COVID Specific | 13 | 13 | $46.41 | $603 |
Medicare prescription drug claims, 2024
In 2024, the drug James M Orrell prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,127 prescriptions and refills. In total James M Orrell wrote 27,926 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,127 | 6,114 | 646 | $20K |
| Metoprolol Succinate Generic | 1,304 | 3,752 | 379 | $19K |
| Amlodipine Besylate Generic | 1,215 | 3,497 | 369 | $7,908 |
| Levothyroxine Sodium Generic | 1,161 | 3,311 | 311 | $11K |
| Losartan Potassium Generic | 1,009 | 2,829 | 305 | $9,675 |
| Lisinopril Generic | 860 | 2,520 | 270 | $5,114 |
| Tramadol Hcl Generic | 727 | 729 | 166 | $5,765 |
| Metformin Hcl Generic | 725 | 2,049 | 219 | $4,984 |
| Furosemide Generic | 724 | 1,994 | 230 | $3,521 |
| Pantoprazole Sodium Generic | 722 | 1,997 | 219 | $11K |
| Omeprazole Generic | 617 | 1,785 | 201 | $7,316 |
| Pravastatin Sodium Generic | 562 | 1,670 | 170 | $6,042 |
| Famotidine Generic | 452 | 1,230 | 142 | $6,289 |
| Tamsulosin Hcl Generic | 442 | 1,241 | 147 | $8,314 |
| Eliquis Apixaban | 401 | 975 | 109 | $549K |
Brand drugs: 3,168 claims; generic drugs: 24,499 claims; opioid claims: 917.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James M Orrell $584 ($584 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $180.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $154 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $147 |
| Lilly USA, LLC LLY | 1 | $21.71 |
| Daiichi Sankyo Inc. 4568.T | 1 | $18.49 |
| Astellas Pharma US Inc 4503.T | 1 | $18.39 |
| Dexcom, Inc. DXCM | 1 | $17.49 |
| Corcept Therapeutics CORT | 1 | $13.93 |
| Pfizer Inc. PFE | 1 | $13.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.